InvestorsHub Logo

venus537

06/27/20 3:30 PM

#283257 RE: marjac #283189

marjac-

So the obviousness patents go back into the orange book and are considered valid again?

What happens if some other drug manufacturer tries to sell gVascepa which prompts a lawsuit by Amarin? Is the defendant not allowed to cite Judge Du's ruling?

caddiedad

06/27/20 4:53 PM

#283279 RE: marjac #283189

Hi Marjac, this Vacatur scenario would seem to be the best type of settlement but has to be agreed to by both R and H collectively.
What is a sensible $ amount and change in time frame for pre 2029 to market agreement vs. binary appeals court decision? Maybe Teva and Apotex are tells that we can’t quite decipher currently?